Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT2A receptors

被引:31
|
作者
Blaazer, Antoni R. [1 ]
Smid, Pieter [2 ]
Kruse, Chris G. [1 ,2 ]
机构
[1] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands
[2] Solvay Pharmaceut, Res Labs, NL-1381 CP Weesp, Netherlands
关键词
5-HT2A receptors; drug design; phenylalkylamines; serotonin; structure-activity relationships;
D O I
10.1002/cmdc.200800133
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Agonist activation of central 5-HT2A receptors results in diverse effects, such as hallucinations and changes of consciousness. Recent findings indicate that activation of the 5-HT2A receptor also leads to interesting physiological responses, possibly holding therapeutic value. Selective agonists are needed to study the full therapeutic potential of this receptor. 5-HT2A ligands with agonist profiles are primarily derived from phenylalkylamines, indolealkylamines, and certain piperazines. Of these, phenylalkylamines, most notably substituted phenylisopropylamines, ore considered the most selective agonists for 5-HT2 receptors. This review summarizes the structure-activity relationships (SAR) of phenylalkylamines as agonist ligands for 5-HT2A receptors. Selectivity is a central theme, as is selectivity for the 5-HT2A receptor and for its specific signaling pathways. SAR data from receptor affinity studies, functional assays, behavioral drug discrimination as well as human studies are discussed.
引用
收藏
页码:1299 / 1309
页数:11
相关论文
共 50 条
  • [1] Structure-Activity Relationships of Constrained Phenylethylamine Ligands for the Serotonin 5-HT2 Receptors
    Isberg, Vignir
    Paine, James
    Leth-Petersen, Sebastian
    Kristensen, Jesper L.
    Gloriam, David E.
    PLOS ONE, 2013, 8 (11):
  • [2] Structure-activity relationships of serotonin 5-HT7 receptors ligands: A review
    Thirumaran, Sangeetha-Laura
    Lepailleur, Alban
    Rochais, Christophe
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 183
  • [3] Synthesis, affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors and structure-activity relationships of a series of cyproheptadine analogues
    Honrubia, MA
    Rodriguez, J
    Dominguez, R
    Lozoya, E
    Manaut, F
    Seijas, JA
    Villaverde, MC
    Calleja, JM
    Cadavid, MI
    Maayani, S
    Sanz, F
    Loza, MI
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1997, 45 (05) : 842 - 848
  • [4] Synthesis and Structure-Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2c Agonists
    Hansen, Martin
    Phonekeo, Karina
    Paine, James S.
    Leth-Petersen, Sebastian
    Begtrup, Mikael
    Braeuner-Osborne, Hans
    Kristensen, Jesper L.
    ACS CHEMICAL NEUROSCIENCE, 2014, 5 (03): : 243 - 249
  • [5] Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists
    Rorsted, Emil M.
    Jensen, Anders A.
    Smits, Gints
    Frydenvang, Karla
    Kristensen, Jesper L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (09) : 7224 - 7244
  • [6] THE ROLE OF 5-HT2A RECEPTORS IN ANTIPSYCHOTIC ACTIVITY
    SCHMIDT, CJ
    SORENSEN, SM
    KEHNE, JH
    CARR, AA
    PALFREYMAN, MG
    LIFE SCIENCES, 1995, 56 (25) : 2209 - 2222
  • [7] Holographic Quantitative Structure-Activity Relationships of Tryptamine Derivatives at NMDA, 5HT1A and 5HT2A Receptors
    Palangsuntikul, Rungtiva
    Berner, Heinz
    Berger, Michael L.
    Wolschann, Peter
    MOLECULES, 2013, 18 (08) : 8799 - 8811
  • [8] Differences in agonist-independent activity of 5-HT2A and 5-HT2C receptors revealed by heterologous expression
    Grotewiel, MS
    Sanders-Bush, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 359 (01) : 21 - 27
  • [9] Differences in agonist-independent activity of 5-HT2A and 5-HT2C receptors revealed by heterologous expression
    M. S. Grotewiel
    E. Sanders-Bush
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1999, 359 : 21 - 27
  • [10] Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update
    Modica, Maria N.
    Lacivita, Enza
    Intagliata, Sebastiano
    Salerno, Loredana
    Romeo, Giuseppe
    Pittala, Valeria
    Leopoldo, Marcello
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (19) : 8475 - 8503